Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Post by josameyeron Jan 12, 2012 9:38am

392 Views

Post# 19395575

To disect hole GF11-249 Black Fox.complex

Core width 18m 11.69 gpt au. 3m-3.96gpt au ,6m 33.57gptau, 3m 63.54gpt au , 3.59m gpt5.14au and 0.50m at 13.92 gpt.au.These are the results for GF11-249. These results look very good to me. I am no expert in mining , however I would like a expert opinion on these latest results. I given one example for hole GF11-249 there are more.These latest results of high grade ore, are results over thick intervals. It seems to me that we have a good potential to increase our resource base. Bonus these results are all in close proximity of the mine..Cheers Josa.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features